Announcements

Announcements
 
 
BMGF – Gates Foundation  [to 3 Nov 2018 ]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.
 
 
Bill & Melinda Gates Medical Research Institute    [to 3 Nov 2018 ]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X   [to 3 Nov 2018 ]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.
 
 
CEPI – Coalition for Epidemic Preparedness Innovations  [to 3 Nov 2018 ]
http://cepi.net/
No new digest content identified.
 
 
EDCTP    [to 3 Nov 2018 ]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
1 November 2018
EDCTP and Wellcome Trust organise session at ASTMH 2018
EDCTP and the Wellcome Trust organised a session on controlled Human Infection Studies in low- and middle-income countries as a contribution to the ASTMH 2018 programme. The symposium (session 169) takes place on 1 November from 08:00-09:45.
 
 
Emory Vaccine Center    [to 3 Nov 2018 ]
http://www.vaccines.emory.edu/
No new digest content identified.
 
 
European Medicines Agency  [to 3 Nov 2018 ]
http://www.ema.europa.eu/ema/
News and press releases
No new digest content identified.
 
 
European Vaccine Initiative  [to 3 Nov 2018 ]
http://www.euvaccine.eu/news-events
No new digest content identified.
 
 
FDA [to 3 Nov 2018 ]
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
November 01, 2018 –
Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health and Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research on agency’s warning to consumers about genetic tests that claim to predict patients’ responses to specific medications
 
 
Fondation Merieux  [to 3 Nov 2018 ]
http://www.fondation-merieux.org/
Mérieux Foundation co-organized event
Case Management working group / Global Task Force on Cholera Control (GTFCC)
November 5 – 6, 2018 – Les Pensieres Center for Global Health, Veyrier-du-Lac (France)
 
Mérieux Foundation co-organized event
Dengue pre-vaccination screening based on serostatus: rapid tests and implementation strategies
January 14 – 16, 2019 – Les Pensières Center for Global Helath, Veyrier du Lac (France)
 
 
Gavi [to 3 Nov 2018 ]
https://www.gavi.org/
31 October 2018
200,000 girls in Senegal to be protected this year against cervical cancer
… The vaccines, funded by Gavi, the Vaccine Alliance and the Government of Senegal, will reach close to 200,000 nine-year-old girls across the country this year and a further 900,000 girls aged 11-14 years next year. UNICEF, WHO and partners will work on implementation alongside the Senegal Ministry of Health and Social Welfare and the Ministry of National Education….

30 October 2018
Hundreds of thousands of children set to be protected against the leading cause of pneumonia in Haiti
Port-au-Prince, 30 October 2018 – The government of Haiti formally introduced yesterday pneumococcal conjugate vaccine (PCV) into its routine immunisation programme, which will protect hundreds of thousands of Haitian children against pneumococcal disease, the leading cause of pneumonia… With this introduction, as many as 270,000 Haitian children will routinely receive PCV every year – along with pentavalent and rotavirus vaccines which Haiti introduced with support from Gavi, the Vaccine Alliance in 2012 and 2014.
 
 
GHIT Fund   [to 3 Nov 2018 ]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical
No new digest content identified.
 
 
Global Fund  [to 3 Nov 2018 ]
https://www.theglobalfund.org/en/news/
Voices
What’s new about the New Nets Project?
31 October 2018
The Global Fund and Unitaid are each investing US$33 million from 2018 to 2022 to introduce new insecticide-treated nets to fight malaria-carrying mosquitoes.
 
 
Hilleman Laboratories   [to 3 Nov 2018 ]
http://www.hillemanlabs.org/
No new digest content identified.
 
 
Human Vaccines Project   [to 3 Nov 2018 ]
http://www.humanvaccinesproject.org/media/press-releases/
Event
Towards a Universal Influenza Vaccine: Lessons from the Great Influenza Pandemic of 1918 to Now
November 15-16, 2018 I Nashville, TN
The Human Vaccines Project is hosting a scientific summit featuring prominent researchers and thought leaders to discuss cutting-edge influenza research. The 2-day meeting will bring together leading scientists, clinicians and public health specialists including: John Barry, James E. Crowe, Jr., Senator Bill Frist, and Laurie Garrett.  Find a full agenda at:
www.humanvaccinesproject.org/talks/universalinfluenzavaccinesummit

November 01, 2018
Human Vaccines Project Launches New Study to Decode Immune Responses to Influenza
 
 
IAVI  [to 3 Nov 2018 ]
https://www.iavi.org/newsroom
No new digest content identified.
 
 
IFFIm
http://www.iffim.org/library/news/press-releases/
No new digest content identified.
 
 
IVAC  [to 3 Nov 2018 ]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
October 2018
Commentary: Pneumonia, Diarrhea, and Measles force Bangladeshi households to make difficult financial decisions when illnesses arise
Few diseases have as much power to cause wide-ranging impact among the population as pneumonia, diarrhea, and measles. These three illnesses can cause long-term disability and can require a significant amount of care. In addition to the pain and the risk of death or disability, people experiencing these illnesses face economic consequences now rising like out-of-pocket expenditures.
 
 
IVI   [to 3 Nov 2018 ]
http://www.ivi.int/
01/11/2018
The GTFCC Marks a Year of Progress Toward Ending Cholera Worldwide
 [See Milestones above for more detail]
 
 
JEE Alliance  [to 3 Nov 2018 ]
https://www.jeealliance.org/
No new digest content identified.
 
 
MSF/Médecins Sans Frontières  [to 3 Nov 2018 ]
http://www.msf.org/
Central African Republic
More than 10,000 seek refuge in Batangafo hospital
2 Nov 2018

Refugees, IDPs and people on the move
“Leaving the country to seek asylum is often the only option for survival”
29 Oct 2018
 
 
NIH  [to 3 Nov 2018 ]
http://www.nih.gov/news-events/news-releases
No new digest content identified.
 
 
PATH  [to 3 Nov 2018 ]
https://www.path.org/media-center/
No new digest content identified.
 
 
Sabin Vaccine Institute  [to 3 Nov 2018 ]
http://www.sabin.org/updates/pressreleases
No new digest content identified.
 
 
UNAIDS [to 3 Nov 2018 ]
http://www.unaids.org/en
2 November 2018
Civil society cooperation network for the Americas and the Caribbean launched

2 November 2018
New data dashboard launched in the Asia and the Pacific region

1 November 2018
New commitment to primary health care

31 October 2018
HIVR4P 2018 highlights new possibilities for HIV prevention

30 October 2018
Training the next generation of Russian doctors on HIV-related stigma and discrimination

29 October 2018
Global HIV prevention targets at risk
 
 
UNICEF  [to 3 Nov 2018 ]
https://www.unicef.org/media/press-releases
Selected Press Releases/Reports/Statements
Press release
In Mexico, children traveling with migrant caravan still in need of protection and support – UNICEF
01/11/2018

Press release
More than 80,000 children returned from Angola to DR Congo in urgent need of humanitarian assistance – UNICEF
30/10/2018

Press release
Global Task Force on Cholera Control marks a year of progress toward ending cholera worldwide
01/11/2018

[See Milestones above for more detail]
 
 
Vaccine Confidence Project  [to 3 Nov 2018 ]
http://www.vaccineconfidence.org/
No new digest content identified.
 
 
Vaccine Education Center – Children’s Hospital of Philadelphia  [to 3 Nov 2018 ]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.
 
 
Wellcome Trust  [to 3 Nov 2018 ]
https://wellcome.ac.uk/news
31 October 2018
How to make sense of the brain’s billions of neurons
A unique global collaboration has produced a new technology that will transform the way we study the brain. Neuropixels allow simultaneous recordings from many hundreds of neurons over multiple brain regions.
 
 
The Wistar Institute   [to 3 Nov 2018 ]
https://www.wistar.org/news/press-releases
No new digest content identified.
 
 
World Organisation for Animal Health (OIE)   [to 3 Nov 2018 ]
http://www.oie.int/en/for-the-media/press-releases/2018/
31/10/18
Ministers agree on international action to address antimicrobial resistance in animals and to safeguard medicines for humans and animals alike
[See Milestones above for more detail]
 
 
::::::
 
 
BIO    [to 3 Nov 2018 ]
https://www.bio.org/insights/press-release
No new digest content identified.
 
 
DCVMN – Developing Country Vaccine Manufacturers Network  [to 3 Nov 2018 ]
http://www.dcvmn.org/
29 October 2018 to 31 October 2018
19th DCVMN Annual General Meeting
Kunming / China
 
 
IFPMA   [to 3 Nov 2018 ]
http://www.ifpma.org/resources/news-releases/
Published on: 29 October 2018
The R&D biopharmaceutical industry supports the Astana Declaration and renewed political commitment towards the importance of primary health care

26 October 2018, Astana – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the body accredited by the United Nations (UN) to represent the R&D biopharmaceutical industry attended Astana at the Global Conference on Primary Health Care on 25-26 October, co-hosted by the Government of Kazakhstan, WHO and UNICEF. R&D biopharmaceutical industry announced its support for the Astana Declaration and welcomed the renewed political commitment towards the importance of primary health care.  The industry body used the occasion to present a number of initiatives that are being pioneered to improve access to treatments and systems that ensure access at the primary care level.

Thomas Cueni, Director General, IFPMA delivered the following message at the Global Conference on Primary Health Care: “The research-based biopharmaceutical industry acknowledges that it needs to do more and do better to bring the fruits of its innovation to all, regardless of economic circumstances. Our industry is much more than a supplier of medicines and vaccines and is pioneering ways to overcome the multiple barriers to access to quality healthcare. Developing more collaborations at the primary health care level will enable healthcare companies to deliver products and services more efficiently and can accelerate progress towards reaching Universal Health Coverage”…
 
 
PhRMA    [to 3 Nov 2018 ]
http://www.phrma.org/press-room
No new digest content identified.